World Journal of Surgery

, Volume 35, Issue 5, pp 1063–1071 | Cite as

Clinicopathological Features and Outcomes of Young Patients with Hepatocellular Carcinoma after Hepatectomy

  • Kazuki TakeishiEmail author
  • Ken Shirabe
  • Jun Muto
  • Takeo Toshima
  • Akinobu Taketomi
  • Yoshihiko Maehara



There are few reports about hepatectomy for young patients with hepatocellular carcinoma (HCC), and the significance of resection for young patients remains unknown. The present study aimed to investigate retrospectively the clinicopathological features and outcomes after hepatectomy of young HCC patients.


Among 610 patients who underwent curative hepatectomy for HCC between January 1987 and December 2007, 13 patients younger than 40 years of age were defined as the young group. Because none of the young group had hepatitis C virus antibodies (HCVAb), 246 patients aged above 40 years without HCVAb were defined as the older group. The clinicopathological findings and outcomes after hepatectomy were compared between the two groups.


In the young group, 7 patients had hepatitis B surface antigen and 3 other patients had hepatitis B core antibodies. The young group had better liver function but more advanced HCC, with a large tumor size and a high incidence of portal vein invasion compared with the older group. Major hepatectomy was more frequently chosen in the young group than in the older group. There was no significant difference in the incidences of postoperative complications. The overall survival tended to be better in the young group than in the older group (p = 0.057).


Hepatitis B virus-related HCC was common inthe younger group of patients reported here. Although the young patients had advanced HCC, there were no significant differences in the complication rate and the overall survival rate of the young and older groups. Aggressive hepatic resection for young patients would contribute to improved survival and should be recommended.


Tace Young Group Major Hepatectomy Postoperative Liver Failure Portal Vein Tumor Thrombosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Conflict of interest



  1. 1.
    El-serag HB (2002) Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 35:S72–S78PubMedCrossRefGoogle Scholar
  2. 2.
    Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2:533–543PubMedCrossRefGoogle Scholar
  3. 3.
    Shiratori Y, Yoshida H, Omata M (2001) Different clinicopathological features of hepatocellular carcinoma in relation to causative agents. J Gastroenterol 36:73–78PubMedCrossRefGoogle Scholar
  4. 4.
    Kiyosawa K, Uemura T, Ichijo T et al (2004) Hepatocellular carcinoma: recent trends in Japan. Gastroenterology 127:S17–S26PubMedCrossRefGoogle Scholar
  5. 5.
    Stroffolini T, Andreone P, Andriulli A et al (1998) Characteristics of hepatocellular carcinoma in Italy. J Hepatol 29:944–953PubMedCrossRefGoogle Scholar
  6. 6.
    Cho SJ, Yoon JH, Hwang SS et al (2007) Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients? J Gastroenterol Hepatol 22:1226–1231PubMedCrossRefGoogle Scholar
  7. 7.
    Chen CH, Chang TT, Cheng KS et al (2006) Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients. Liver Int 26:766–773PubMedCrossRefGoogle Scholar
  8. 8.
    Aramaki M, Kawano K, Sasaki A et al (2005) Hepatocellular carcinoma in young adults. Hepatogastroenterology 52:1795–1797PubMedGoogle Scholar
  9. 9.
    Yamazaki Y, Kakizaki S, Sohara N et al (2007) Hepatocellular carcinoma in young adults: the clinical characteristics, prognosis, and findings of a patient survival analysis. Dig Dis Sci 52:1103–1107PubMedCrossRefGoogle Scholar
  10. 10.
    Ng IO, Ng MM, Lai EC et al (1996) Pathologic features and patient survival in hepatocellular carcinoma in relation to age. J Surg Oncol 61:134–137PubMedCrossRefGoogle Scholar
  11. 11.
    Lam CM, Chan AO, Ho P et al (2004) Different presentation of hepatitis B-related hepatocellular carcinoma in a cohort of 1863 young and old patients—implications for screening. Aliment Pharmacol Ther 19:771–777PubMedCrossRefGoogle Scholar
  12. 12.
    Chang PE, Ong WC, Lui HF et al (2008) Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome. J Gastroenterol 43:881–888PubMedCrossRefGoogle Scholar
  13. 13.
    Shimada M, Takenaka K, Fujiwara Y et al (1998) Risk factors linked to postoperative morbidity in patients with hepatocellularcarcinoma. Br J Surg 85:195–198PubMedCrossRefGoogle Scholar
  14. 14.
    Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedCrossRefGoogle Scholar
  15. 15.
    Lack EE, Neace C, Vawter GF (1983) Hepatocellular carcinoma. Review of 32 cases in childhood and adolescence. Cancer 52:1510–1515PubMedCrossRefGoogle Scholar
  16. 16.
    Liver Cancer Study Group of Japan (2003) The general rules for the clinical and pathological study of primary liver cancer. Second English edition. Kanehara, TokyoGoogle Scholar
  17. 17.
    Bruix J, Sherman M (2005) AASLD practice guideline: management of hepatocellular carcinoma. Hepatology 42:1208–1236PubMedCrossRefGoogle Scholar
  18. 18.
    De Bac C, Stroffolini T, Gaeta GB et al (1994) Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter Italian study. Hepatology 20:1225–1230PubMedCrossRefGoogle Scholar
  19. 19.
    Schoniger-Hekele M, Muller C, Kutilek M et al (2001) Hepatocellular carcinoma in central Europe: prognostic features and survival. Gut 48:103–109PubMedCrossRefGoogle Scholar
  20. 20.
    Kew MC (1981) Clinical, pathologic, and etiologic heterogeneity in hepatocellular carcinoma: evidence from southern Africa. Hepatology 1:366–369PubMedCrossRefGoogle Scholar
  21. 21.
    Merican I, Guan R, Amarapuka D et al (2000) Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 15:1356–1361PubMedCrossRefGoogle Scholar
  22. 22.
    Lai CL, Yuen MF (2007) The natural history of chronic hepatitis B. J Viral Hepat 14(Suppl 1):6–10PubMedGoogle Scholar
  23. 23.
    Ko CY, Hsu HC, Shen MR et al (2008) Epigenetic silencing of CCAAT/enhancer-binding protein delta activity by YY1/polycomb group/DNA methyltransferase complex. J Biol Chem 283:30919–30932PubMedCrossRefGoogle Scholar
  24. 24.
    Agrawal S, Hofmann WK, Tidow N et al (2007) The C/EBPdelta tumor suppressor is silenced by hypermethylation in acute myeloid leukemia. Blood 109:3895–3905PubMedCrossRefGoogle Scholar
  25. 25.
    Weber A, Boger R, Vick B et al (2010) Hepatocyte-specific deletion of the antiapoptotic protein myeloid cell leukemia-1 triggers proliferation and hepatocarcinogenesis in mice. Hepatology 51:1226–1236PubMedGoogle Scholar
  26. 26.
    Fried M, Kalra J, Iardi CF et al (1987) Hepatocellular carcinoma in a long-term survivor of acute lymphocytic leukemia. Cancer 60:2548–2552PubMedCrossRefGoogle Scholar
  27. 27.
    Guariso G, Fiorio S, Altavilla G et al (1998) Congenital absence of the portal vein associated with nodular hyperplasia of the liver and cystic dysplasia of the kidney. Eur J Paediatr 157:287–290CrossRefGoogle Scholar
  28. 28.
    Matsuoka Y, Ohtomo K, Okubo T et al (1992) Congenital absence of the portal vein. Gastrointest Radiol 17:31–33PubMedCrossRefGoogle Scholar
  29. 29.
    Bannasch P (1996) Pathogenesis of hepatocellular carcinoma: sequential cellular, molecular and metabolic changes. Prog Liver Dis 14:161–197PubMedGoogle Scholar
  30. 30.
    Tso PL, Bringaze WL 3rd, Dauterive AH et al (1987) Gastric carcinoma in the young. Cancer 59:1362–1365PubMedCrossRefGoogle Scholar
  31. 31.
    de la Monte SM, Hutchins GM, Moore GW (1988) Influence of age on the metastatic behavior of breast carcinoma. Hum Pathol 19:529–534CrossRefGoogle Scholar
  32. 32.
    Theuer CP, Kurosaki T, Taylor TH et al (1998) Unique features of gastric carcinoma in the young: a population-based analysis. Cancer 83:25–33PubMedCrossRefGoogle Scholar
  33. 33.
    Msika S, Benhamiche AM, Jouve JL et al (2000) Prognostic factors after curative resection for gastric cancer. A population-based study. Eur J Cancer 36:390–396PubMedCrossRefGoogle Scholar
  34. 34.
    The Cancer of the Liver Italian Program (CLIP) investigators (1998) A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 28:751–755CrossRefGoogle Scholar
  35. 35.
    Kudo M, Chung H, Osaki Y (2003) Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 38:207–215PubMedCrossRefGoogle Scholar
  36. 36.
    Huang ZQ, Xu LN, Yang T et al (2009) Hepatic resection: an analysis of the impact of operative and perioperative factors on morbidity and mortality rates in 2008 consecutive hepatectomy cases. Chin Med J 122:2268–2277PubMedGoogle Scholar
  37. 37.
    Shimada M, Yamashita Y, Hamatsu T et al (2000) Surgical indications for advanced hepatocellular carcinoma. Hepatogastroenterology 47:1095–1099PubMedGoogle Scholar
  38. 38.
    Llovet JM (2005) Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 40:225–235PubMedCrossRefGoogle Scholar
  39. 39.
    Taketomi A, Toshima T, Kitagawa D et al (2010) Predictors of extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 17:2740–2746PubMedCrossRefGoogle Scholar
  40. 40.
    Yoon YS, Kim HK, Kim J et al (2010) Long-term survival and prognostic factors after pulmonary metastasectomy in hepatocellular carcinoma. Ann Surg Oncol 17:2795–2801PubMedCrossRefGoogle Scholar
  41. 41.
    He J, Zeng ZC, Tang ZY et al (2009) Clinical features and prognostic factor in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy. Cancer 115:2710–2720PubMedCrossRefGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2011

Authors and Affiliations

  • Kazuki Takeishi
    • 1
    Email author
  • Ken Shirabe
    • 1
  • Jun Muto
    • 1
  • Takeo Toshima
    • 1
  • Akinobu Taketomi
    • 1
  • Yoshihiko Maehara
    • 1
  1. 1.Department of Surgery and Science, Graduate School of Medical SciencesKyushu UniversityFukuokaJapan

Personalised recommendations